SRF per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹77.01₹61.91₹42.40₹45.06₹72.95
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹77.01₹61.91₹42.40₹45.06₹72.95
₹473.75₹473.75₹425.96₹387.26—
₹616.19₹532.57₹495.68₹443.24—
—₹86.15₹83.92₹70.64—
₹24.91₹24.91₹42.37−₹4.15—
—₹8.98₹7.19₹7.21—
29.629.629.629.6—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SRF₹2,358.60

SRF Ltd.

· Chemicals
₹ CrorePeersNAVINFLUORFLUOROCHEMPIINDUPLCOROMANDELSOLARINDSPIDILITINDBASFMcap ₹69,914 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS72.9545.0642.4061.9177.01
Diluted EPS72.9545.0642.4061.9177.01
Book Value per Share—387.26425.96473.75473.75
Revenue per Share—443.24495.68532.57616.19
Cash Flow per Share—70.6483.9286.15—
Free Cash Flow per Share—-4.1542.3724.9124.91
Dividends per Share—7.217.198.98—
Shares Outstanding (cr)—29.629.629.629.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.